Risk factors for OS and EFS: multivariate analysis
Risk factors . | Overall survival RR (95% CI) . | Event-free survival RR (95% CI) . |
---|---|---|
Age at diagnosis, y | ||
1 to 10 | 1.0 | 1.0 |
Younger than 1 | 3.8 (3.1-4.6)* | 3.3 (2.8-4.0)* |
Older than 10 | 2.3 (2.1-2.6)* | 1.8 (1.6-1.9)* |
Initial WBC count | ||
Lower than 50 000/mL | 1.0 | 1.0 |
50 000/mL or higher | 1.7 (1.5-1.9)* | 1.4 (1.2-1.5)* |
Initial platelet count | ||
50 000/mL or higher | 1.0 | 1.0 |
Less than 50 000/mL | 1.0 (0.9-1.1)2-153 | 1.1 (1.0-1.2)‡ |
Sex | ||
Female | 1.0 | 1.0 |
Male | 1.1 (1.0-1.3)† | 1.2 (1.1-1.3)* |
Liver size | ||
Normal | 1.0 | 1.0 |
Enlarged | 1.1 (0.9-1.2)2-153 | 1.2 (1.0-1.3)† |
Spleen size | ||
Normal | 1.0 | 1.0 |
Enlarged | 1.3 (1.2-1.4)* | 1.1 (1.0-1.3)‡ |
Era | ||
Recent | 1.0 | 1.0 |
Early | 1.4 (1.3-1.6)* | 1.5 (1.4-1.6)* |
Ethnicity | ||
White | 1.0 | 1.0 |
Black | 1.4 (1.1-1.6)* | 1.4 (1.2-1.7)* |
Hispanic | 1.4 (1.2-1.6)* | 1.3 (1.2-1.5)* |
Asian | 0.6 (0.4-0.9)‡ | 0.8 (0.6-1.1)2-153 |
Risk factors . | Overall survival RR (95% CI) . | Event-free survival RR (95% CI) . |
---|---|---|
Age at diagnosis, y | ||
1 to 10 | 1.0 | 1.0 |
Younger than 1 | 3.8 (3.1-4.6)* | 3.3 (2.8-4.0)* |
Older than 10 | 2.3 (2.1-2.6)* | 1.8 (1.6-1.9)* |
Initial WBC count | ||
Lower than 50 000/mL | 1.0 | 1.0 |
50 000/mL or higher | 1.7 (1.5-1.9)* | 1.4 (1.2-1.5)* |
Initial platelet count | ||
50 000/mL or higher | 1.0 | 1.0 |
Less than 50 000/mL | 1.0 (0.9-1.1)2-153 | 1.1 (1.0-1.2)‡ |
Sex | ||
Female | 1.0 | 1.0 |
Male | 1.1 (1.0-1.3)† | 1.2 (1.1-1.3)* |
Liver size | ||
Normal | 1.0 | 1.0 |
Enlarged | 1.1 (0.9-1.2)2-153 | 1.2 (1.0-1.3)† |
Spleen size | ||
Normal | 1.0 | 1.0 |
Enlarged | 1.3 (1.2-1.4)* | 1.1 (1.0-1.3)‡ |
Era | ||
Recent | 1.0 | 1.0 |
Early | 1.4 (1.3-1.6)* | 1.5 (1.4-1.6)* |
Ethnicity | ||
White | 1.0 | 1.0 |
Black | 1.4 (1.1-1.6)* | 1.4 (1.2-1.7)* |
Hispanic | 1.4 (1.2-1.6)* | 1.3 (1.2-1.5)* |
Asian | 0.6 (0.4-0.9)‡ | 0.8 (0.6-1.1)2-153 |